1. Home
  2. CREX vs XLO Comparison

CREX vs XLO Comparison

Compare CREX & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CREX
  • XLO
  • Stock Information
  • Founded
  • CREX N/A
  • XLO 2016
  • Country
  • CREX United States
  • XLO United States
  • Employees
  • CREX N/A
  • XLO N/A
  • Industry
  • CREX EDP Services
  • XLO Biotechnology: Pharmaceutical Preparations
  • Sector
  • CREX Technology
  • XLO Health Care
  • Exchange
  • CREX Nasdaq
  • XLO Nasdaq
  • Market Cap
  • CREX 35.2M
  • XLO 35.7M
  • IPO Year
  • CREX N/A
  • XLO 2021
  • Fundamental
  • Price
  • CREX $2.60
  • XLO $0.70
  • Analyst Decision
  • CREX Strong Buy
  • XLO Buy
  • Analyst Count
  • CREX 1
  • XLO 2
  • Target Price
  • CREX $6.00
  • XLO $3.00
  • AVG Volume (30 Days)
  • CREX 62.3K
  • XLO 431.6K
  • Earning Date
  • CREX 08-13-2025
  • XLO 08-14-2025
  • Dividend Yield
  • CREX N/A
  • XLO N/A
  • EPS Growth
  • CREX N/A
  • XLO N/A
  • EPS
  • CREX N/A
  • XLO N/A
  • Revenue
  • CREX $48,218,000.00
  • XLO $15,001,000.00
  • Revenue This Year
  • CREX $10.03
  • XLO $300.08
  • Revenue Next Year
  • CREX $18.84
  • XLO $1.87
  • P/E Ratio
  • CREX N/A
  • XLO N/A
  • Revenue Growth
  • CREX N/A
  • XLO 536.45
  • 52 Week Low
  • CREX $1.28
  • XLO $0.62
  • 52 Week High
  • CREX $4.85
  • XLO $1.70
  • Technical
  • Relative Strength Index (RSI)
  • CREX 48.71
  • XLO 52.67
  • Support Level
  • CREX $2.19
  • XLO $0.64
  • Resistance Level
  • CREX $2.77
  • XLO $0.71
  • Average True Range (ATR)
  • CREX 0.21
  • XLO 0.04
  • MACD
  • CREX 0.03
  • XLO 0.00
  • Stochastic Oscillator
  • CREX 70.69
  • XLO 70.10

About CREX Creative Realities Inc.

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

Share on Social Networks: